[Recent advances in proPSA on early detection in prostate cancer]
- PMID: 16398372
[Recent advances in proPSA on early detection in prostate cancer]
Abstract
The precursor of prostate specific antigen (proPSA) are distinct molecular forms of free PSA in serum. proPSA is comprised of native proPSA as well as several truncated forms, in which [-2] proPSA and [-4] proPSA are more prostate cancer (PCa)-associated than [-7] proPSA and [-5] proPSA. Clinical studies have recently provided evidence that [-2] proPSA can significantly improve the detection of PCa, particularly in patients with total serum PSA values less than 4 microg/L. In this paper, the mechanism and characteristics of proPSA formation and impact of proPSA on the early detection of PCa are reviewed.
Similar articles
-
Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.J Urol. 2003 Sep;170(3):723-6. doi: 10.1097/01.ju.0000086940.10392.93. J Urol. 2003. PMID: 12913682
-
Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.Rinsho Byori. 2004 Mar;52(3):223-30. Rinsho Byori. 2004. PMID: 15137320 Review.
-
Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.Anticancer Res. 2007 Jul-Aug;27(4A):1833-6. Anticancer Res. 2007. PMID: 17649780 Clinical Trial.
-
A (-5, -7) proPSA based artificial neural network to detect prostate cancer.Eur Urol. 2006 Nov;50(5):1014-20. doi: 10.1016/j.eururo.2006.04.011. Epub 2006 May 2. Eur Urol. 2006. PMID: 16697520
-
PSA and other tissue kallikreins for prostate cancer detection.Eur J Cancer. 2007 Sep;43(13):1918-26. doi: 10.1016/j.ejca.2007.06.006. Epub 2007 Aug 3. Eur J Cancer. 2007. PMID: 17689069 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous